Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aspirin MI Primary Prevention Labeling Urged In Bayer Citizen Petition

This article was originally published in The Tan Sheet

Executive Summary

Aspirin therapy led to a statistically significant 32% reduction in first myocardial infarctions among over 55,000 subjects evaluated in a meta-analysis of five primary prevention studies conducted by Bayer Consumer Care

Related Content

Aspirin Tops Three Rx Drugs In Preventing Heart Attack – Consumers Union
Aspirin Use For CVD Prevention Low Among At-Risk Patients – Study
Aspirin Therapy Lowers Stroke Risk In Women, MI Risk In Men – JAMA
Bayer Low Dose Ads Urge Consumers To “Do More” In Cardiac Prevention
Aspirin For MI Primary Prevention Indication Needs More Study, Panel Says
Aspirin/MI Prevention Patient Identification Process Sought By FDA
Bayer HOT Aspirin Study Interpretation Gets Lukewarm FDA Feedback
Bayer appointment
Aspirin PSA
Bayer “ASAP” Campaign Includes Aspirin Donations, Focus On Women





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts